Home›Companies›Biotech & Pharma›Duracrin

Duracrin, LLC

No website or LinkedIn page we could confirm. Why?
Updated Nov 11, 2026·Latest SEC filing Feb 25, 2026·Suggest an edit

About Duracrin

Duracrin is a private company based in New Haven, Connecticut, incorporated in 2025 in Delaware. It has reported $1,000,000 raised in one offering on Form D since February 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 3, 2026Feb 25, 2026$1,000,000fully sold2$500KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Duracrin's Form D filed Feb 25, 2026.

Craig Crews
Craig Crews
Director
Also a co-founder & scientific advisor, quarry thera, director at Quarry Thera and Quarry Thera and an officer and a, director at Quarry Thera.
SC
Sean Cassidy
Chief Financial Officer and director

Sources

  1. SECDuracrin, LLC filing history